Gene DeFelice, Alexandra Snyder
Adaptive Biotechnologies has appointed Gene DeFelice to senior vice president and general counsel and Alexandra Snyder to translational medicine lead for Adaptive Research.
DeFelice has served as general counsel for several public healthcare and technology companies, including as primary counsel at Roche Diagnostics. He will join Adaptive's executive team to implement a legal infrastructure for clinical applications of next-generation sequencing technologies.
Snyder has joined Adaptive from Memorial Sloan Kettering Cancer Research Center where she specialized in tumor immunogenomics and response to checkpoint blockade immunotherapy.